Meloxicam [Mobic] in Juvenile Rheumatoid Arthritis (JRA)
Public ClinicalTrials.gov record NCT00034853. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 12 Week Double-blind Randomized Trial, With a 12 Week Open-label Extension, to Investigate the Efficacy and Safety of Meloxicam Oral Suspension Administered Once Daily and Naproxen Oral Suspension Administered Twice Daily in Children With Juvenile Rheumatoid Arthritis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To obtain safety, efficacy, pharmacokinetic and dosing information for meloxicam oral suspension in children with Juvenile Rheumatoid Arthritis (JRA)
Study identification
- NCT ID
- NCT00034853
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 180 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 2 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2000 (Type not available)
- Primary completion
- Jun 2003 (Actual)
- Completion
- Not listed
- Last update posted
- Nov 1, 2013
Started 2000
United States locations
- U.S. sites
- 29
- U.S. states
- 23
- U.S. cities
- 28
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| 107.235.23 Arkansas Children's Hospital | Little Rock | Arkansas | — | — |
| 107.235.17 Valley Children's Hospital | Madera | California | — | — |
| 107.235.37 | San Diego | California | — | — |
| 107.235.4 Boehringer Ingelheim Investigational Site | Denver | Colorado | — | — |
| 107.235.12 Boehringer Ingelheim Investigational Site | Hartford | Connecticut | — | — |
| 107.235.13 Alfred I. DuPont Hospital for Children | Wilmington | Delaware | — | — |
| 107.235.36 Arthritis Associates Clinical Research of South Florida | Delray Beach | Florida | — | — |
| 107.235.21 Miami Children's Hospital | Miami | Florida | — | — |
| 107.235.38 Clinical Research Dept #7006 | Saint Petersberg | Florida | — | — |
| 107.235.8 Boehringer Ingelheim Investigational Site | Chicago | Illinois | — | — |
| 107.235.7 Boehringer Ingelheim Investigational Site | Kansas City | Kansas | — | — |
| 107.235.25 University of Louisville | Louisville | Kentucky | — | — |
| 107.235.16 Children's Hospital - Department of Rheumatology | New Orleans | Louisiana | — | — |
| 107.235.26 Deparment of Rheumatology | Boston | Massachusetts | — | — |
| 107.235.2 E15 Mayo Clinic | Rochester | Minnesota | — | — |
| 107.235.18 Washington University School of Medicine | St Louis | Missouri | — | — |
| 107.235.9 Boehringer Ingelheim Investigational Site | St Louis | Missouri | — | — |
| 107.235.31 Department of Pediatrics | Omaha | Nebraska | — | — |
| 107.235.35 Arthritis and Rheumatic Disease Center | Livingston | New Jersey | — | — |
| 107.235.24 The Children's Hospital of Buffalo | Buffalo | New York | — | — |
| 107.235.19 Columbia Presbyterian Medical Center | New York | New York | — | — |
| 107.235.22 Oklahoma Medical Research Foundation | Oklahoma City | Oklahoma | — | — |
| 107.235.33 Healthcare Research Consultants | Tulsa | Oklahoma | — | — |
| 107.235.32 Arthritis and Osteoporosis Center | Duncansville | Pennsylvania | — | — |
| 107.235.39 Division of Ambulatory Pediatrics | Providence | Rhode Island | — | — |
| 107.235.10 Texas Scottish Rite Hospital | Dallas | Texas | — | — |
| 107.235.1 University of Utah School of Medicine | Salt Lake City | Utah | — | — |
| 107.235.30 Children's Hospital | Seattle | Washington | — | — |
| 107.235.20 Medical College of Wisconsin | Milwaukee | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 8 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00034853, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 1, 2013 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00034853 live on ClinicalTrials.gov.